rosiglitazone has been researched along with Respiratory Distress Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, XJ; Ji, XX; Li, QQ; Lu, XX; Luo, L | 1 |
| Geng, ZL; Liu, D; Wang, YL; Zeng, BX; Zeng, L; Zhang, SF; Zhang, SH | 1 |
| Bhatia, M | 1 |
| Cuzzocrea, S | 1 |
1 review(s) available for rosiglitazone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptors and acute lung injury.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Humans; Ligands; PPAR alpha; PPAR gamma; Prostaglandin D2; Respiratory Distress Syndrome; Rosiglitazone; Thiazolidinediones | 2006 |
3 other study(ies) available for rosiglitazone and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Rosiglitazone Reduces Apoptosis and Inflammation in Lipopolysaccharide-Induced Human Umbilical Vein Endothelial Cells.
Topics: Anti-Inflammatory Agents; Apoptosis; Cell Survival; Chemokine CXCL12; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; Janus Kinase 2; Lipopolysaccharides; PPAR gamma; Reactive Oxygen Species; Receptors, CXCR4; Respiratory Distress Syndrome; Rosiglitazone; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2018 |
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.
Topics: Anilides; Animals; Endotoxemia; Lipopolysaccharides; Lung; Male; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Rats, Wistar; Respiratory Distress Syndrome; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Tyrosine | 2005 |
Peroxisome proliferator-activated receptor-gamma ligands protect against lung injury: potential therapeutic targets?
Topics: Animals; Humans; Lung; Nitric Oxide; Nitric Oxide Synthase Type II; PPAR gamma; Rats; Respiratory Distress Syndrome; Rosiglitazone; Thiazolidinediones; Tyrosine | 2005 |